Lower is better: ENHANCE affair

Lower is better: ENHANCE affair

Ezetimibe lowers the intestinal absorption of cholesterol, being complementary to the effects of statin. To check its efficacy in lowering the carotid intima-media thickness, in 2002 a multicenter international trial called ENHANCE was started, in order to assess by ultrasound the regression of athe...

Full description

Bibliographic Details
Main Authors:	Sabino Scardi, Paolo Umari, Bianca Maria D’Agata
Format:	Article
Language:	English
Published:	PAGEPress Publications 2016-01-01
Series:	Monaldi Archives for Chest Disease
Subjects:	ENHANCE trial ezetimibe simvastatin
Online Access:	https://www.monaldi-archives.org/index.php/macd/article/view/421

Similar Items

NEWS OF EVIDENCE-BASED MEDICINE: RESULTS OF THE IMPROVE-IT TRIAL AND THEIR IMPLICATIONS FOR CLINICAL PRACTICE
by: S. Yu. Martsevich
Published: (2015-09-01)

Physical Stability and Viscoelastic Properties of Co-Amorphous Ezetimibe/Simvastatin System
by: Justyna Knapik-Kowalczuk, et al.
Published: (2019-03-01)

Efficacy, safety and tolerability of ongoing statin plus ezetimibe versus doubling the ongoing statin dose in hypercholesterolemic Taiwanese patients: an open-label, randomized clinical trial
by: Yu Chih-Chieh, et al.
Published: (2012-05-01)

Simultaneous spectrophotometric determination of ezetimibe and simvastatin in pharmaceutical preparations using chemometric techniques
by: Ismail Murat Palabiyik, et al.
Published: (2008-01-01)

Simvastatin and Ezetimibe-Loaded Nanofibers Administered Locally to Augment Bone Healing
by: Shayan Amiri, et al.
Published: (2021-01-01)

Hypolipidemic and pleiotropic effects of a combination of simvastatin and ezetimibe in patients with different types of hyperlipidemia
by: A B Sumarokov, et al.
Published: (2014-12-01)

Efficacy of a combination of cholesterol absorption and synthesis inhibitors in the correction of hyperlipidemia and dietary fat intolerance in patients with coronary heart disease (ESTHETICS trial)
by: M. G Bubnova, et al.
Published: (2013-03-01)

Effect on non-vascular outcomes of lowering LDL cholesterol in patients with chronic kidney disease: results from the Study of Heart and Renal Protection
by: C. Reith, et al.
Published: (2017-05-01)

Low incidence of paradoxical reductions in HDL-C levels in dyslipidemic patients treated with fenofibrate alone or in combination with ezetimibe or ezetimibe/simvastatin
by: Farnier Michel, et al.
Published: (2011-11-01)

Changes in cholesterol absorption and cholesterol synthesis caused by ezetimibe and/or simvastatin in men
by: Thomas Sudhop, et al.
Published: (2009-10-01)

Ezetimibe/simvastatin 10/40 mg versus atorvastatin 40 mg in high cardiovascular risk patients with primary hypercholesterolemia: a randomized, double-blind, active-controlled, multicenter study
by: Hing Ling Paul, et al.
Published: (2012-01-01)

Gender characteristics of lipid correction and anti-remodelling effects of various lipid-lowering therapies in patients with metabolic syndrome
by: V. V. Skibitskiy, et al.
Published: (2013-12-01)

Effects of simvastatin/ezetimibe on microparticles, endothelial progenitor cells and platelet aggregation in subjects with coronary heart disease under antiplatelet therapy
by: L.M. Camargo, et al.
Published: (2014-05-01)

Impact of Combination Therapy with Ezetimibe/Simvastatin Treatment on the Neointimal Response to Biodegradable Polymer Biolimus-Eluting Stent Implantation in Patients with Acute Myocardial Infarction: Serial Assessment with Optical Coherence Tomography
by: Yongcheol Kim, et al.
Published: (2018-10-01)

LDL-C: lower is better for longer—even at low risk
by: Peter E. Penson, et al.
Published: (2020-10-01)

Efeitos da associação de sinvastatina e ezetimiba na cinética de quilomícrons artificiais em pacientes portadores de doença arterial coronária estável
by: Otávio Celeste Mangili
Published: (2012)

Efeitos da associação de sinvastatina e ezetimiba na cinética de quilomícrons artificiais em pacientes portadores de doença arterial coronária estável
by: Mangili, Otávio Celeste
Published: (2012)

Identification, synthesis and characterization of process related desfluoro impurity of ezetimibe and HPLC method validations
by: Esen Bellur Atici, et al.
Published: (2015-12-01)

The role of ezetimibe and simvastatin in modulating intestinal cholesterol transport, chylomicron profile and chylomicron-remnant uptake by the arterial wall in a rodent model of the metabolic syndrome
by: Warnakula, Samantha
Published: (2010)

Differences in synthesis and absorption of cholesterol of two effective lipid-lowering therapies
by: S.H. Kasmas, et al.
Published: (2012-11-01)

Differences in synthesis and absorption of cholesterol of two effective lipid-lowering therapies
by: S.H. Kasmas, et al.
Published: (2012-11-01)

Zebrafish as a Model for the Study of Lipid-Lowering Drug-Induced Myopathies
by: Magda Dubińska-Magiera, et al.
Published: (2021-05-01)

Efficacy and Tolerability of a Fixed-Dose Combination of Rosuvastatin and Ezetimibe Compared with a Fixed-Dose Combination of Simvastatin and Ezetimibe in Brazilian Patients with Primary Hypercholesterolemia or Mixed Dyslipidemia: A Multicenter, Randomized Trial
by: Antonio Carlos Amedeo Vattimo, MD, MSc, et al.
Published: (2020-01-01)

The effects of ezetimibe on omega-3 fatty acid absorption in the prevention of cardiovascular disease
by: Blackwood, David Palmer
Published: (2012)

The effects of ezetimibe on omega-3 fatty acid absorption in the prevention of cardiovascular disease
by: Blackwood, David Palmer
Published: (2012)

Simvastatin treatment does not affect serum Vitamin D concentrations in patients with dyslipidemia: A randomized double-blind placebo-controlled cross-over trial
by: Mohsen Mazidi, et al.
Published: (2016-01-01)

Simvastatin-Nicotinamide Co-Crystals: Formation, Pharmaceutical Characterization and in vivo Profile
by: Khan FM, et al.
Published: (2020-10-01)

Indications of PCSK9 Inhibitors for Patients at High and Very High Cardiovascular Risk
by: Paulo Eduardo Ballvé Behr, et al.

Improvement in the Oral Bioavailability and Efficacy of New Ezetimibe Formulations—Comparative Study of a Solid Dispersion and Different Micellar Systems
by: Carlos Torrado-Salmerón, et al.
Published: (2020-07-01)

ESCADRA: a randomised study. Part I: lipid-lowering effectiveness, safety and tolerability of ezetimibe, initial doses of original statins, and the combination of ezetimibe with initial doses of statins in patients with coronary heart disease and hyperlipidemia
by: M. Yu. Zubareva, et al.
Published: (2010-12-01)

COMPARISON OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC DRUGS OF SIMVASTATIN IN PATIENTS WITH HYPERLIPIDAEMIA AND HIGH RISK OF ISCHEMIC HEART DISEASE COMPLICATIONS
by: S. N. Tolpygina, et al.
Published: (2016-01-01)

Comparison of Renal Effects of Ezetimibe–Statin Combination versus Statin Monotherapy: A Propensity-Score-Matched Analysis
by: Jaehyun Bae, et al.
Published: (2020-03-01)

Ezetimibe potential in cardiology practice
by: A. A. Lyakishev, et al.
Published: (1970-01-01)

EXPLORING LIPID LOWERING ACTIVITY OF CASSIA FISTULA AND SIMVASTATIN, IN HYPERLIPIDEMIC MICE
by: Usman Nawaz, et al.
Published: (2019-06-01)

Is insulin topical gel better than simvastatin topical gel in full thickness wound?
by: Timotius Hansen Arista, et al.
Published: (2019-03-01)

The study of bioequivalence of twо ezetimib drugs after single oral administration in healthy volunteers
by: Veronika V. Tolkacheva, et al.
Published: (2019-01-01)

Molecular mechanisms of toxicity of simvastatin, widely used cholesterol-lowering drug. A review
by: Kaminsky Yury, et al.
Published: (2010-06-01)

Pharmacokinetic interactions and tolerability of rosuvastatin and ezetimibe: an open-label, randomized, multiple-dose, crossover study in healthy male volunteers
by: Kim H, et al.
Published: (2018-04-01)

High performance liquid chromatographic method for determination of ezetimibe in pharmaceutical formulation tablets
by: Hossein Danafar
Published: (2016-09-01)

A Study to Compare Hypolipidemic Effects of Allium Sativum (Garlic) Alone and in Combination with Atorvastatin or Ezetimibe in Experimental Model
by: Sil Sudipta, et al.
Published: (2021-03-01)